Rome, Italy

Angelo Guglielmotti

USPTO Granted Patents = 25 


 

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 90(Granted Patents)


Company Filing History:


Years Active: 2000-2018

Loading Chart...
Loading Chart...
Loading Chart...
25 patents (USPTO):Explore Patents

Title: Angelo Guglielmotti: A Pioneer in Pharmaceutical Innovations

Introduction

Angelo Guglielmotti, based in Rome, Italy, is a distinguished inventor with a remarkable portfolio of 25 patents. His contributions have significantly advanced the field of pharmaceuticals, particularly through his innovative approaches to treating inflammatory diseases and other health disorders.

Latest Patents

Among his latest patents is the development of a novel benzoyl derivative of 3-aminocarbazole. This invention encompasses a pharmaceutical composition designed to combat various health issues, including inflammatory processes, pain, fever, tumors, Alzheimer's disease, and atherosclerosis. Additionally, Guglielmotti's pharmaceutical composition for the treatment of MCP-1 mediated inflammatory diseases demonstrates a combination of a 1-benzyl-3-hydroxymethylindazole derivative with pressure lowering and cholesterol lowering agents. This synergistic formulation effectively reduces MCP-1 levels, thereby improving the inflammatory response and minimizing complications for patients suffering from related diseases.

Career Highlights

Throughout his career, Angelo Guglielmotti has worked with prominent companies in the pharmaceutical sector. Notably, he has been associated with Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. and Angelini Ricerche S.p.A. Società Consortile. His work in these organizations has been instrumental in driving forward critical research initiatives and product developments.

Collaborations

Collaboration has been a significant aspect of Guglielmotti’s career. He has had the opportunity to work alongside talented colleagues, including Nicola Cazzolla and Guido Furlotti. Together, they have contributed to many innovative projects that address pressing medical challenges.

Conclusion

Angelo Guglielmotti stands as a testament to the impact of innovative thinking in the pharmaceutical industry. His extensive patent portfolio and collaborative efforts underscore his commitment to improving health outcomes through groundbreaking inventions. His work continues to pave the way for new treatments and therapies for inflammatory diseases and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…